United States Últimas notícias

Eli Lilly (NYSE:LLY) received U.S. Food and Drug Administration approval on September 24, 2026, for Onswik, a once-weekly basal insulin treatment for adults with type 2 diabetes.

Biodesix (NASDAQ:BDSX) announced progress on two molecular residual disease (MRD) testing programs designed to detect circulating tumor DNA (ctDNA) in blood samples following cancer treatment.

Vertiv (NYSE:VRT) agreed on September 24, 2026, to acquire King Environmental Services (KES), a Europe-based provider of fluid-management services for data centers and critical infrastructure applications.

Fervo Energy (NYSE:FRVO) announced that its Cape Station geothermal project in Utah achieved First Power on September 24, 2026, marking the start of electricity exports from the facility.

Sequans Communications (NYSE:SQNS) completed the sale of its remaining 314 Bitcoin holdings, ending its Bitcoin treasury strategy and refocusing on its semiconductor business.

Yields on the US government's longest-dated bonds climbed to the highest level in more than two decades, the latest milestone notched in an extended bond selloff driven by inflation and fiscal concerns. The rate on 30-year Treasuries rose as much as four basis points on Thursday to 5.44%, the highest since 2004, after Brent crude oil prices jumped. It follows a surge this week that left yields across maturities around the highest levels since 2007. JP Morgan Private Bank's Global Investment Strategy Co-Head Grace Peters joined Lizzy Burden and Stephen Carroll on Bloomberg radio to discuss. Christopher Pitt

MediciNova (NASDAQ:MNOV) announced the completion of the last patient’s final visit in the double-blind portion of its Phase 2b/3 COMBAT-ALS trial evaluating MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS).

aTyr Pharma (NASDAQ:ATYR) announced FDA alignment on the planned Phase 3 study protocol for efzofitimod in patients with pulmonary sarcoidosis on September 24, 2026.

Kyverna Therapeutics (NASDAQ:KYTX) reported updated clinical data for its investigational CAR-T therapy miv-cel (mivocabtagene autoleucel) in stiff person syndrome (SPS) and generalized myasthenia gravis (gMG).

Leland Miller, China Beige Book CEO, joins Bloomberg's Anna Edwards on "Bloomberg Brief" to look ahead to the Trump-Xi summit in Washington. He says that the US side has seen a lot of non-compliance from their Chinese counterparts, which have resulted in more frequent check-ins. Miller adds that the Board of Investment is intended to stabilize the relationship and not expand bilateral investment.

RTX (NYSE:RTX) and United Airlines marked the delivery of the first Airbus A321XLR aircraft powered by Pratt & Whitney’s GTF Advantage engine on September 24, 2026.

MGM Resorts International (NYSE:MGM) shares fell 8.38% to $34.68 in premarket trading after People withdrew its proposal to acquire the remaining public shares of the casino operator.